Tianda Pharmaceuticals Ltd. has announced changes to its management team, effective 27 June 2025. Mr. CHIU Sung Hong will no longer be a member of the Nomination Committee. Dr. XIAN Yanfang has been appointed as a member of the Nomination Committee, while Mr. LAM Yat Fai has been appointed as the lead independent non-executive director. Other roles and functions of Mr. Chiu, Dr. Xian, and Mr. Lam at the Board remain unchanged.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianda Pharmaceuticals Ltd. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.